After years of wrangling within member states, the European Parliament has finally given approval to the commercial growing of genetically modified (GM) crops across the continent. The vote last month backs a new directive that will end a virtual three-year moratorium on granting licenses for the commercial development of GM foods. The standstill followed concerns about the impact of the new crops on the environment. "This is a significant step in terms of habituating people to GM products," said David Bowe, the British member of the European Parliament (MEP) who liaises between the European Parliament and the Commission on GM issues. "The moratorium is dead," he said.
Several applications from biotech companies for licenses to plant GM products for commercial use have been on hold during the moratorium. Dozens of requests to develop GM organisms are now expected from major multinational firms in the wake of the new legislation. The testing of GM crops for environmental impact has been allowed but no planting for commercial use has been permitted. This will change under the new laws.
All fresh applications will be subject to approval by a majority vote in a committee made up of representatives of EU member states. However, it will be illegal under EU law for any member state to ban or stop the commercial planting of a crop cleared at a European level unless serious and justified concerns over environmental or economic impact can be demonstrated. Because of the time needed for trials, and the 'implementation period' allowed, the effect of the new laws is not likely to be felt for up to two years.
A spokesperson for Britain's Department of the Environment, Transport and the Regions, which is responsible for the current UK noncommercial GM crop trials, said the reform "put in place new safeguards rather than opening any floodgates."
There is distrust of the food industry and official regulators, following numerous scares
The British environment minister, Michael Meacher, has announced the sites for the first set of trials for the coming season involving genetically modified beet, sugar beet and oilseed rape. Such openness has backfired on some occasions in the past when environmental protesters have destroyed the trial crops.
But anti-GM campaigners have grave concerns. The new directive "is not enough to protect the environment, consumers and farmers from GM crops," said Adrian Bebb of Friends of the Earth. There are concerns that the use of antibioticresistance marker genes will only be phased out gradually after commercial crops have been planted and that pollen from GM crops might adversely affect neighboring conventional crops.
There are also clear signs that consumers are not yet happy to accept the new foods. There is distrust of the food industry and official regulators, following numerous scares from salmonella, through Escherichia coli, to bovine spongiform encephalopathy (BSE or mad cow disease). Opponents argue that, although consumers may be taking risks by eating genetically modified food, all of the benefits go into the pockets of (often US-owned) biotech companies. And there are genuine differences between farming practices in the US and Europe, where many farms are still comparatively small and wildlife is dependent on particular farming techniques, that critics fear will be changed by the new crops.
Earlier this year, the two UK supermarket chains Tesco and Asda announced they would no longer sell meat or milk from any animal fed with genetically modified soya or maize. The two companies, which between them control more than one third of the UK grocery market, said they will switch their imports form North America to Brazil where commercial GM plantings are illegal. Other companies such as McDonald's, Burger King, Iceland and Marks & Spencer have already acted to remove GM ingedients in animal products.
The British prime minister, Tony Blair, appeared to be an early enthusiast for GM foods believing they would bolster Britain's strong biotechnology industry. But recently he has become more cautious: "There's no doubt that there is potential for harm both in terms of human safety and in the diversity of environment from GM foods or crops."
The new laws face strong opposition from other European nations. The French have said that they will try to block all new 
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Europe opens the door to GM crops
Commercial growing of genetically modified crops now looks set to go ahead but persuading consumers about their merits may be a more difficult task. Nigel Williams reports licences for commercial growing of GM crops. They say that the question of legal liability of biotech companies for any damage done by the new crops has not been satisfactorily resolved and are concerned about 'traceability' -provisions to ensure that consumers know what they are eating. Italy, Greece, Denmark, Austria and Luxembourg may back the French position.
But in Italy, the government faced a backlash last month against its tough stand banning all open-field experiments with GMOs. The Green Party agriculture minister, Alfonso Pecario Scanio, faced a lobby of 1,500 of Italy's most eminent scientists callling for a lifting of the ban. Nobel laureate Rita Levi-Montalcini attacked the government as 'neoLuddites'. After talks with the prime minister, Giuliano Amato, the scientists got the go ahead for openfield experiments but only at a single site, after a watchdog committee has been created and guidelines are established. But with a general election due this spring, some researchers believe they have been offered an empty promise.
Yet the vehemence of opposition to trials of genetically modified crops is surprising in the view of Europe's willingness to embrace biotechnology for medical and other uses. There has, for example, been little ethical concern about the introduction of genetically engineered insulin for treating diabetes, or a genetically engineered version of the enzyme chymosin for cheesemaking. Ironically, because chymosin is traditionally extracted from calves' stomachs, the innovation has made cheese more acceptable for many vegetarians.
And many researchers are pinning hopes on discoveries such as the 'golden rice' described earlier this year. Whereas many current GM crops seem primarily to benefit the owner or grower, golden rice is targeted at the consumer. By introducing three genes into rice to make it rich in beta carotene, a precursor of vitamin A, the Swiss researchers who developed it believe the new rice could be a valuable source of the vitamin for many millions of people whose staple food is rice but whose diets are deficient in the vitamin. An estimated 125 million children worldwide are deficient in vitamin A, including 250,000 in South-east Asia who go blind each year because of the problem.
While new GM crops may help to win over people, one area of agriculture remains implacably opposed to GMOs -the organic sector. Demand for organic products has risen dramatically in recent years and BSE is widely seen as a watershed spurring this new demand. "For the first time people realized that merely attempting to ensure a culinary end product was safe to eat was not a good enough approach. We had to look at the entire process by which food is produced," says a spokesperson for Britain's Soil Association, which licenses organic growers. In France, sales of organic products have increased by 25% over the past two years as BSE cases have been confirmed in that country. And in both Sweden and Austria, more than 10% of agricultural land is now used for organic production and the area is growing across countires in Europe. GMOs face a very tough battle ahead.
